Cornago et al. demonstrated that SAHA and VPA inhibit glioma cell growth in vitro by inducing the production of reactive oxygen species (ROS) that promote cancer cell death and alter cell cycle progression by decreasing the expression of G2 checkpoint kinases Wee1 and checkpoint kinase 1 (Chk1)8. The gene discussed is CHEK1; the disease is central nervous system cancer.